Dr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.51, versus $0.51 reported last year. Revenue for the quarter came in at $599 million, versus $581 million reported last year.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.